Article
Cover
RJPS Journal Cover Page

RJPS Vol No: 14 Issue No: 3 eISSN: pISSN:2249-2208

Article Submission Guidelines

Dear Authors,
We invite you to watch this comprehensive video guide on the process of submitting your article online. This video will provide you with step-by-step instructions to ensure a smooth and successful submission.
Thank you for your attention and cooperation.

Original Article

Shweta Kolli1*, M Nitin2 , Shivkumar Inamdar2 , Dastapur Ashok kumar2

1Dept. of Pharmacology, MAM college of Pharmacy, Gulbarga. 2 Department of Pharmacology, HKES’s MTRIPS, Kalaburagi-585105.

*Corresponding author:

Ms. Shweta Kolli, Asst. Professor, Department of Pharmacology, MAM college of Pharmacy, Gulbarga. E-mail: kollishweta349@gmail.com

Received date: July 08, 2020; Accepted date: December 30, 2020;  Ahead of Print

Received Date: 2020-07-08,
Accepted Date: 2020-12-30,
Published Date: 2021-03-31
Year: 2021, Volume: 11, Issue: 1, Page no. 15-21, DOI: 10.26463/rjps.11_1_3
Views: 1761, Downloads: 65
Licensing Information:
CC BY NC 4.0 ICON
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0.
Abstract

In the traditional system of medicine of Ayurveda, the medicinal plants that are known to modulate the immune response fall under the concept of rasayana. These plants also have been attributed with anabolic, antistress/ adaptogenic, nootropic, antioxidant and anti-aging properties. A good immunomodulatory drug can be a breakthrough in the treatment of diseases where an abnormal immune response is the pathological cause such as cancer, autoimmune diseases and natural or acquired immune deficiency syndromes. The aim of the present study was to investigate the immunomodulatory activity of methanolic and aqueous extracts of the whole plant of Achyranthes aspera Linn. in Swiss Albino mice and Wistar Albino rats. The first model was cyclophosphamide induced myelosuppression where cyclophosphamide was used to suppress the immune system in Swiss Albino mice and evaluated the plant extracts in reversal of myelosuppression by analyzing various hematological parameters. In the second model involving Arthus type immediate hypersensitivity, the plant extracts were evaluated for protection from Arthus type immediate hypersensitivity in Wistar Albino rats. The potency of AEAA (aqueous extract of Achyranthes aspera) and MEAA (methanolic extract of Achyranthes aspera) were compared. Both AEAA and MEAA have shown significant immunomodulatory activity in both the cases. However, MEAA was found to have higher potency (p< 0.01) compared to AEAA (p< 0.05).

<p>In the traditional system of medicine of Ayurveda, the medicinal plants that are known to modulate the immune response fall under the concept of rasayana. These plants also have been attributed with anabolic, antistress/ adaptogenic, nootropic, antioxidant and anti-aging properties. A good immunomodulatory drug can be a breakthrough in the treatment of diseases where an abnormal immune response is the pathological cause such as cancer, autoimmune diseases and natural or acquired immune deficiency syndromes. The aim of the present study was to investigate the immunomodulatory activity of methanolic and aqueous extracts of the whole plant of Achyranthes aspera Linn. in Swiss Albino mice and Wistar Albino rats. The first model was cyclophosphamide induced myelosuppression where cyclophosphamide was used to suppress the immune system in Swiss Albino mice and evaluated the plant extracts in reversal of myelosuppression by analyzing various hematological parameters. In the second model involving Arthus type immediate hypersensitivity, the plant extracts were evaluated for protection from Arthus type immediate hypersensitivity in Wistar Albino rats. The potency of AEAA (aqueous extract of Achyranthes aspera) and MEAA (methanolic extract of Achyranthes aspera) were compared. Both AEAA and MEAA have shown significant immunomodulatory activity in both the cases. However, MEAA was found to have higher potency (p&lt; 0.01) compared to AEAA (p&lt; 0.05).</p>
Keywords
Immunomodulation, Achyranthes aspera Linn., Myelosuppression, Immediate hypersensitivity
Downloads
  • 1
    FullTextPDF
Article

Introduction

Achyranthes aspera Linn. belongs to the family Amaranthaceae commonly known as apamarg or uttrani in Kannada. It grows in the wild on field boundaries, and as a weed throughout India, up to an altitude of 2100 meters and in the South Andaman Islands.1 It is also found in Baluchistan, Ceylon, Asia, Africa, Australia, and America. The different parts of the plant are used in native, traditional remedies as ingredients in combination with more active remedies. Apamarg is being used in traditional system of medicines as a laxative, and is considered useful in treating dropsy, piles, boils, skin eruptions etc. The dried parts of the plant are given to children for colic, gonorrhea, and the water extract is used in the treatment of pneumonia. In Las Bela, the plant is used as a cure for coughs and rheumatism.2

In most recent studies, Apamarg is widely studied for its medicinal properties and has been reported to have spermicidal activity3 , postcoital antifertility activity,4 antiparasitic activity,5 hypoglycaemic activity,6 antioxidant activity,7,8 chemopreventive action,9 hepatoprotective activity,10 analgesic and antipyretic11,12,13, anti-inflammatory activity,14 mild to moderate antibiotic activity against B. subtilis, E. coli, and P. aeruginosa,15 nephroprotective activity,16 anti-depressant effect,17 diuretic effect,18 bronchoprotective effect,19 and immunostimulatory properties.20,21 Achyranthes aspera leaf extract has also been reported to show both thyroidstimulating and antiperoxide activities.22

The plant is widely used in the treatment of various ailments and is a constituent of many formulations. Therefore, the primary objective of this study was to evaluate the immunomodulatory activity of Achyranthes aspera Linn. as MEAA and AEAA, in rats and also to compare the potency of these extracts.

Materials And Methods

Collection of plant material

Achyranthes aspera Linn. plants were collected from the local area of Kalaburagi, Karnataka, India. The plant was authenticated by botanist Dr. Pratibha Sanghapurkar, Professor and HOD, Department of Botany, H.K.E.S’s V. G. College for Women, Kalaburagi, Karnataka. Ref No.: HKES/VGC/BOT/08/2018-2019

Preparation of different extracts

Methanolic extract

The shade dried powder of the whole plant was extracted with methanol using continuous Soxhlet apparatus, at 40˚ C for 48 h to obtain the methanolic extract of the plant. The filtrates of the extract were concentrated, until dry, at temperature 40˚C.

Aqueous extract

About 200 g of the powder was taken in a round bottom flask and dissolved in 1000 ml of distilled water and 10 ml of chloroform (preservative) for 24 h with occasional shaking in a closed vessel. Marc was removed by filtering the extract and concentrated on a water bath at 40˚C to get a semi-solid mass. These extracts were stored in airtight containers and refrigerated at 10˚C.

Preparation of test samples

From previous literature of acute toxicity study the methanolic extract of whole plant of Achyranthes aspera Linn. when administered, 250 and 500 mg/kg by oral route to young and adult Swiss Albino mice, did not show any toxic symptoms and mortality.35 In another toxicity study conducted on Swiss Albino mice it was found that ethanolic extract of Achyranthes aspera Linn. was found to be safe at a limited dose of 2000 mg/kg.34

Acute oral toxicity study of aqueous extract of Achyranthes aspera Linn. using Swiss Albino mice reported that AEAA did not show any signs or symptoms of toxicity or mortality during the observation period, at the dose of 2000 mg/kg.29

Oral toxicity studies of both alcoholic and aqueous extract of the plant are found to be safe at the dose of 2000 mg/kg, therefore 1/10th of this dose, which is 200 mg/kg was used in a subsequent study.

Methanolic extract was prepared to attain suitable dosage forms by suspending in 1% sodium methyl cellulose,23 and aqueous extracts were prepared to attain suitable dosage forms by suspending in water for injection.

Animals: Swiss Albino mice (male) weighing between 25-30 g and Wistar Albino rats (male) weighing between 220-250 g, were procured from the Central Animal House, HKES MTRIPS, Kalaburagi. The animals were acclimatized for one week to laboratory conditions. They were maintained in standard conditions of light, temperature, and humidity, which were fed with standard rodent diet and water ad libitum throughout the course of study. The animals were fasted for 12 h prior to the experiment. The study protocol was duly approved by the Institutional Animal Ethical Committee (IAEC), Ref. No. HKES/MTRIPS/IAEC/102/2018-19.

I. Cyclophosphamide induced myelosuppression in Swiss albino mice

Cyclophosphamide (Cycloxan –200 mg powder for intravenous use, Biochem Pharmaceutical Industries Ltd., Mumbai) was used as a standard immunosuppressant, which was procured from authorized pharmacy and dilutions were made using sterile water for injection as instructed on the label of the product.

Procedure

Swiss Albino mice were divided into four groups containing six mice each.

Group 1- Control, received vehicle (1% sodium CMC), orally, for 13 days.

Group 2- Received vehicle orally for 13 days and was injected with cyclophosphamide by tail, intravenously on the 11th, 12th, and 13th days.

Group 3- Received AEAA orally for 13 days and were injected with cyclophosphamide by tail, intravenously on the 11th, 12th, and 13th day, 1 h after the administration of respective doses.

Group 4- Received MEAA, orally for 13 days and were injected with cyclophosphamide by tail, intravenously on the 11th, 12th, and 13th day, 1 h after the administration of respective doses. Blood samples were collected on the 14th day of the experiment by retro-orbital puncture and hematological tests were done for red blood corpuscles count (RBC), percentage of hemogloblin (Hb%), platelets count, total white blood corpuscles (WBC) and differential count (DLC).24

II. Arthus type immediate hypersensitivity (ATIH)

Preparation of Sheep Red Blood Cells (SRBC)

The sheep blood freshly collected from the slaughterhouse was mixed with sterile Alsever’s solution (1:1) and then centrifuged at 3000 rpm for 5 minutes. SRBC were washed 3-4 times with a large quantity of sterile saline solution. The SRBC cell concentration (1 x 108 cells) was adjusted.25

Procedure

The Wistar Albino rats were divided into 5 groups with 6 rats in each group.

All the animals except group 5 were sensitized by intramuscular administration of 0.5 ml of SRBC (sheep red blood cells) suspension 7 days prior to the start of the experiment. Twenty-four hours and one hour prior to induction of Arthus reaction the animals received the treatment as follows,

Group 1: SRBC sensitized animals received solvent alone and served as positive control.

Group 2: SRBC sensitized animals received standard prednisolone p.o. (30 mg/kg) and served as the active control.

Group 3: SRBC sensitized animals received AEAA orally.

Group 4: SRBC sensitized animals received MEAA orally.

Group 5: Nonsensitized animals that received solvent alone served as negative control.

After 24 hours and one hour of the respective treatment, animals were challenged by injection of 0.1 ml of 0.04% solution of purified SRBC solution in the left hind paw. The footpad thickness was measured by plethysmometer at 1, 2, 3 and 5 h after challenging with 0.1 ml of 0.04% solution of purified SRBC solution.26

Results

I. Cyclophosphamide induced myelosuppression in Swiss Albino mice.

Animals treated with cyclophosphamide at the dose of 30 mg/kg by tail intravenously showed significant reduction in total WBC count, DLC, and platelets along with a marginal reduction in RBC and Hb% as compared to the control group. Both AEAA and MEAA at the dose of 200 mg/kg showed statistically significant (P<0.05 and P<0.01) protection from myelosuppression. The mice treated with AEAA and MEAA had higher total WBC and DLC counts along with marginally higher counts in RBC, platelets and Hb% compared to cyclophosphamide alone treated group. However, MEAA showed greater efficacy (P<0.01) than AEAA (P<0.05).

II Arthus type immediate hypersensitivity

The results obtained are summarized in Table 3. Methanolic and aqueous extracts of Achyranthes aspera Linn. produced marked decrease in paw edema which indicates that both extracts are effective in protecting from ATIH reaction. AEAA (P< 0.05) and prednisolone (P< 0.05) were equally potent when compared to the control group. However, methanolic extract of Achyranthes aspera Linn. showed significantly higher (P< 0.01) protection from ATIH reaction when compared to prednisolone (P< 0.05).

Discussion

Alteration of immune system of an organism by any substance is known as immunomodulation. The alteration of immune system can either be specific or nonspecific in nature or sometimes both. If a substance enhances immunity it is an immunostimulant and if it suppresses immunity it is an immunosuppressant.27 However, some substances alter the immune system by normalizing or modulating pathophysiological processes without being specifically stimulative or suppressive and are hence simply named as immunomodulatory agents.28

The chemical constituents found in the methanolic extract of Achyranthes aspera are carbohydrates, steroids, phenolic compounds, tannins, alkaloids, saponins, flavonoids, proteins, and glycosides.30,36 The chemical constituents found in the aqueous extract of Achyranthes aspera are alkaloids, carbohydrates, tannins, saponins, glycosides, triterpenoids and flavonoids.29

Cyclophosphamide, an immunosuppressive agent, acts at various levels on cells involved in defense mechanism, against various invaders by inhibiting both cellmediated and humoral immunity.31 Cyclophosphamide significantly decreases the Hb, RBC, and WBC counts. Cyclophosphamide treatment for the period of 3 days showed a significant reduction in Hb, total WBC count and RBC count and thereby exerted immunosuppressant effect when compared to control animals. Treatment with the extracts after administration of myelosuppressive drug i.e., Cyclophosphamide resulted in significantly higher counts on various hematological parameters when compared to the group that was administered only cyclophosphamide. Methanolic extract showed significantly higher (P< 0.01) total WBC and DLC count when compared to the aqueous extract.

Arthus reaction is the type III hypersensitivity reaction caused by deposition of immune complex on the tissues followed by activation of the complement system and inflammatory reactions, resulting in cell injury. First exposure to the antigen results in weak antigen-antibody reactions. Exposure to the same antigen results in chronic antigen-antibody complex formation which our immune system fails to eliminate from body fluids leading to deposition in the tissues and inflammation.32 In the present study, animals were immunized with SRBC seven days prior to start of the experiment. After 24 h and one hour of treatment, animals were challenged by SRBC, the footpad thickness was then measured by plethysmometer at 1, 2, 3 and 5 h. Both AEAA and MEAA showed statistically significant protection from ATIH reaction in Wistar Albino rats. AEAA (P< 0.05) and prednisolone (P< 0.05) were equally potent when compared to the control group. However, MEAA demonstrated greater protection (P< 0.01) from Arthus reaction when compared to AEAA and the standard drug, prednisolone.

Conclusions

Both AEAA and MEAA have shown statistically significant higher count of hematological parameters when compared to the untreated cyclophosphamide group, using cyclophosphamide induced myelosuppression method in Swiss Albino mice. MEAA showed higher efficacy when compared to AEAA. Both AEAA and MEAA demonstrated statistically significant protection from ATIH reaction in Wistar Albino rats. AEAA and prednisolone were equally potent when compared to the untreated control group and MEAA showed higher efficacy than the standard drug, prednisolone.

The activity may be due to the presence of alkaloids, steroids, glycosides, triterpenoids and flavonoids.29, 30, 36, 33 The results suggest that MEAA is a potent immunomodulator than that of AEAA in the first model and in the second model MEAA has shown better protection when compared to AEAA and standard drug, prednisolone from ATIH reaction. This could be due to the presence of β-sitosterol in MEAA.29 β-sitosterol, is a type of steroid found in methanolic extract of Achyranthes aspera Linn.37 which has been reported to have immunomodulatory and antiinflammatory activity. β-sitosterol and its glycosides seem to target specific T-helper lymphocytes and natural killer cells activity and also a dampening effect on overactive antibody responses has also been reported.38 Future investigations should be planned to evaluate the exact mechanism of action of immunomodulatory activity of MEAA.

Conflicts of interest

None.

Acknowledgments

We are thankful to the authorities of H.K.E.S’s MTRIPS, Kalaburagi, for providing the facilities needed for this study  

Supporting File
No Pictures
References
  1. Gupta RK. Medicinal and Aromatic Plants. New Delhi: CBS publishers and distributors; 2010.
  2. Kritikar KR Basu BD. Indian Medicinal Plants. Dehra Dun: International Book Distributors; 2008.
  3. Paul D, Bera S, Jana D, Maiti R, Ghosh D. In vitro determination of the contraceptive spermicidal activity of a composite extract of Achyranthes aspera and Stephania hernandifolia on human semen, Contraception. Epub; 2006; (3): 284-288.
  4. Wadhwa V, Singh MM, Gupta DN, Singh C, Kamboj VP. Contraceptive and Hormonal Properties of Achyranthes aspera in Rats and Hamster. Planta medica; 1986; 52(3): 231-233.
  5. Zahir, AA. Rahuman, C. Kamaraj, A. Bagavan, G. Elango, A. Sangaran, B.S. Kumar Laboratory determination of efficacy of indigenous plant extracts for parasites control. Parasitology Research; 2009; 105(2): 453-461.
  6. Akhtar MS,Iqbal J. Evaluation of the hypoglycaemic effect of Achyranthes aspera in normal and alloxandiabetic rabbits. J Ethnopharmacol; 1991; 31(1): 49-57.
  7. Gayathri DS, Archanah A, Abiramasundari P, Priya V, Uma K, Abirami T. Comparative Evaluation of the Antioxidant Status and In vitro Free Radical Scavenging Activities of Leaves and Roots of Achyranthes aspera. Indian Journal of Nutrition and Dietetics; 2009; 46(12): 485-490.
  8. Malarvili T, Gomathi N. Effect of Achyranthes aspera (Linn) seeds on redox and oxidative status in plasma and selected tissues of rats fed with high doses of fructose. Biosciences Biotechnology Research Asia; 2009; 6(2): 659-664.
  9. Chakraborty A, Brantner A, Mukainaka T, Nobukuni Y, Kuchide M, Konoshima T, et al. Cancer chemopreventive activity of Achyranthes aspera leaves on Epstein-Barr virus activation and twostage mouse skin carcinogenesis. Cancer Lett; 2002; 177(1): 1-5.
  10. Bafna AR, Mishra SH. Effect of methanol extract from Achyranthes aspera Linn. on the hepatotoxicity induced by rifampicin in rats. Ars Pharmaceutica; 2004; 45(4): 343-351.
  11. Sutar NG, Sutar UN, Shar YP, Shaikh IK, Kshirsagar SS. Phytochemical investigation and pharmacological screening of leaves of Achyranthes aspera Linn. as analgesic and antipyretic. Biosciences Biotechnology Research Asia; 2008; 5(2): 841-844.
  12. Mehta FA, Patel BG, Pandya SS, Ahir KB, Patel SB. Antinociceptive and anti-inflammatory activity of Achyranthes aspera Linn. Extracts. Pharmacologyonline; 2009; 3: 978-985.
  13. Neogi NC, Garg RD, Rathor RS. A study on in-vitro antihelmintic activity of aqueous and methanolic extracts of Achyranthes aspera L. leaves against pheritima posthuma. Indian Journal of Pharmacy; 1970; 32(2): 43-46.
  14. Vijaya Kumar S, Sankar P, Varatharajan R. Antiinflammatory activity of roots of Achyranthes aspera. Pharmaceutical Biology; 2009; 47(10): 973- 975.
  15. Khan MTJ, Ahmad K, Alvi MN, et al. Antibacterial and Irritant Activities of Organic Solvent Extracts of Agave americana Linn., Albizzia lebbek Benth. Achyranthes aspera Linn. and Abutilon Indicum Linn - A Preliminary Investigation. Pakistan Journal of Zoology; 2010; 42(1): 93-97.
  16. Jayakumar T, Sridhar MP, Bharathprasad TR, Ilayaraja M, Govindasamy S, Balasubramanian MP. Experimental studies of Achyranthes aspera (L) preventing nephrotoxicity induced by lead in albino rats. Journal of Health Science; 2009; 55(5): 701-708.
  17. Barua CC, Talukdar A, Begum SA, Buragohain B, Roy JD, Borah RS, Lahkar M. Antidepressant-like effect of methanolic extract of Achyranthes aspera Linn. In animal model of depression. Pharmacology online; 2009; 2: 587-594.
  18. Gupta SS, Verma SCL, Ram AK, Tripathi RM. Diuretic effect of the saponin of Achyranthes aspera (Apamarga). Ind.J.Pharmac; 1972; 4(4): 208-214.
  19. Goyal BR, Mahajan SG, Mali RG, Goyal RK, Mehta AA. Beneficial effect of Achyranthes apsera L. in toluene-diisocyanate induced occupational asthma in rats. Global Journal of Pharmacology; 2007; 1(1): 6-12.
  20. Rao YV, Govinda RD, Babu GS, Rao RA. Immunomodulatory activity of Achyranthes aspera on the elicition of antigen-specific murine antibody response. Pharmaceutical Biology; 2002; 40(3): 175-178.
  21. Chakrabarti R, Vasudeva RY. Achyranthes aspera stimulates the immunity and enhances the antigen clearance in Catla catla. International Immunopharmacology; 2006; 6(5): 782-790.
  22. Tahiliani P, Kar A. Achyranthes aspera elevates thyroid hormone levels and decreases hepatic lipid peroxidation in male rats. Journal of Ethnopharmacology; 2000;71(3): 527-532.
  23. . Satpute KL, Jadhav MM, Karodi RS, Patil M.J. Immunomodulatory activity of fruits of Randia dumetorum Lamk. J. pharmacog. & Phytother; 2009; 11: 1-5.
  24. Manjarekar PN, Jolly CL, Narayan S. Comparative studies of immunomodulatory activity of Tinospora sinensis. Fitoterpia; 2001; 71: 254-257.
  25. Sneha JA, Sunitha, Sandhya Rani D, Ganga RM. Immunomodulatory activity for methanolic extract of Trigonella foenum graecum whole plant in Wistar albino rats. AJPC; 2014; 2(9): 1081-1092.
  26. Vogel HG. Drug Discovery and Evaluation: Pharmacological Assays. 3rd ed. New York: Springer reference; 2008.
  27. Makare N, Bodhankar S, Rangari V. Immunomodulatory activity of alcoholic extract of Mangifera indica L. in mice. J Ethnopharmacology; 2001; 78: 133-7.
  28. Bafna AR, Mishra SH. Immunomodulatory activity of methanol extract of roots of Cissampelos pareira Linn. Ars Pharm; 2005; 46: 253-262.
  29. Uma AB, Radha Y, Prachi P, Rahul S. Effect of aqueous extracts of Achyranthes aspera Linn. on experimental animal model for inflammation. Anc Sci Life; 2012; 31(4): 202–206.
  30. Bhawana P, Prachi B, Sheetal S and Shikha S. Study of Physiochemical Analysis of Achyranthes Aspera Extracts. Int J Pharm Sci; Res2014; 5(8): 3378-82.
  31. Winkelstein A. Mechanism of Immunosuppression: Effects of Cyclophosphamide on Cellular Immunity. Blood; 1973; 41(2) 73-74.
  32. . Harsh M. Textbook of Pathology. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd; 2010.
  33. Ibrahim J, Waqas A, Syed NAB. Plant derived immunomodulators: an insight on their preclinical evaluation and clinical trials. Front Plant Sci; 2018; 9: 1178
  34. Mandol S, Ghosh D, Ganapaty S, Reddy SM, Karipeddi R. Evaluation of healing potential of Achyranthes aspera Linn. (Amaranthaceae) seeds in excision, incision, dead space and burn wound model-An-in-vivo study. Pharmacogn.J 2016; 8(3): 300-306
  35. Reddy CV, Kamble A. Toxicity study of Achyranthes aspera. International letters of natural sciences; 2014; ISSN: 2300-9675; 14: 85-86
  36. Kamble A. Phytochemical studies on Achyranthes aspera. World scientific news; 2018; 16-34
  37. Dey A. Achyranthes aspera L: Phytochemical and pharmacological aspects. International journal of pharmaceutical sciences review and research; 2011; 9(2): 72-82.
  38. Bouic PJD Lamprecht JH. Plant sterols and sterolines: A review of their immune-modulating properties; Altern Med Rev 1999; 4(3):170-177.  
HealthMinds Logo
RGUHS Logo

© 2024 HealthMinds Consulting Pvt. Ltd. This copyright specifically applies to the website design, unless otherwise stated.

We use and utilize cookies and other similar technologies necessary to understand, optimize, and improve visitor's experience in our site. By continuing to use our site you agree to our Cookies, Privacy and Terms of Use Policies.